Arca
Skip to content
Tools
Tools

Obsessive compulsive disorder

Drug research and approvals for obsessive compulsive disorder: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 124 studies of obsessive compulsive disorder are recruiting on ClinicalTrials.gov, Health Canada has authorized 10 drug trials for it since 2013, and FDA has 0 approved and 1 open orphan designations naming it.

  • Recruiting worldwide: 124
  • Trials authorized in Canada: 10
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 124 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 5

Phase 3 8

Phase 2 12 of 28

Phase 1 or earlier 6

How its trials ended

552 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 103 whose ending is known, 49% met their primary endpoint, 6% missed it and 46% stopped early.

  • Completed, result not reported23342%
  • Ongoing15929%
  • Status unknown5710%
  • Met its primary endpoint509%
  • Stopped: other or unclear295%
  • Stopped: enrollment or feasibility102%
  • Missed its primary endpoint61%
  • Stopped: sponsor or business decision31%
  • Stopped: funding31%
  • Stopped: lack of efficacy2<1%

Trials authorized in Canada

Newest first; search them all in Canada trials
Feb 27, 2026Imaging presynaptic density in obsessive compulsive disorder with/without comorbid major depressive disorder[18F]SDM-8 inj / [18F]BCPP-EFCentre for Addiction and Mental HealthOngoing
Oct 24, 2023Evaluating the feasibility, clinical effects, and safety of psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: an…Psilocybin (PEX010)Centre for Addiction and Mental HealthOngoing
Jan 13, 2023A clinical trial to evaluate the safety and efficacy of fecal microbiota transplantation in a population with obsessive-compulsive disorderIntestinal microbes recovered from filteration, suspension and ultrafiltration…Governors of The University of CalgaryOngoing
Aug 3, 2022Psilocybin assisted therapy for anxiety and mood disorders: a transdiagnostic open label clinical trial for improving well-being (pam-well)PsilocybinBrain and Cognition Discovery FoundationClosed
Jul 8, 2021Assessment of safety and feasibility of exablate neuro system to perform echo-focusing echo imaging in patients with treatment-resistant neurologic and…Definity (perflutren)InsightecPending
Jun 2, 2021A randomized sham and placebo-controlled trial of adjunctive d-cycloserine in repetitive transcranial magnetic stimulation for obsessive compulsive disorderCycloserineGovernors of The University of CalgaryOngoing
Feb 10, 2021A randomized, double-blind, placebo-controlled trial of adjunctive troriluzole in obsessive compulsive disorder.Troriluzole (BHV-4157)Biohaven TherapeuticsOngoing
Feb 10, 2021A multicenter, long-term open-label safety study of adjunctive troriluzole in subjects with obsessive compulsive disorderTroriluzole (BHV-4157)Biohaven TherapeuticsOngoing
Jan 12, 2021Celecoxib versus placebo as an adjunct to treatment-as-usual in children and youth with obsessive compulsive disorder: a single-site randomized quadruple-blind…CelecoxibThe University of British Columbia & BC Children's Hospital Research InstituteOngoing
Jun 26, 2013A phase II, multi-center, randomized, double-blind, parallel-group, placebo-controlled study to evaluate efficacy and safety of RO4917838 in combination with…Bitopertin (RO4917838)RocheClosed

FDA orphan designations

Approved first, then open designations, newest first
DateDrugSponsorStatus
Oct 12, 2011SarcosineTreatment of obsessive compulsive disorder in pediatric patients (0 to 16 years of age)Guochuan Emil Tsai, MD, PhDDesignated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.